Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis (Q27013703)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis	scientific article

Statements

scholarly article

1 reference

4 references

23 March 2019

22 June 2019

25 June 2019

30 July 2022

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis (English)

0 references

multiple drug resistance

0 references

0 references

multidrug-resistant tuberculosis

3 references

23 March 2019

22 June 2019

25 June 2019

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jia Yin

1

1 reference

Jinqiu Yuan

2

1 reference

Yanhong Hu

3

1 reference

Xiaolin Wei

4

1 reference

language of work or name

1 reference

publication date

2016

1 reference

1 March 2016

4 references

23 March 2019

22 June 2019

25 June 2019

30 July 2022

5 references

23 March 2019

22 June 2019

25 June 2019

30 July 2022

11

1 reference

3

1 reference

e0150511

1 reference

copyright license

Creative Commons Attribution 4.0 International

4 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

30 July 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Directly observed therapy for treating tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

21 March 2017

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

7 April 2017

Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Health-service performance of TB treatment for indigenous and non-indigenous populations in Brazil: a cross-sectional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Ethical aspects of directly observed treatment for tuberculosis: a cross-cultural comparison.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients--a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Systematic review and meta-analysis: a primer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

How does directly observed therapy work? The mechanisms and impact of a comprehensive directly observed therapy intervention of highly active antiretroviral therapy in Peru.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Seven-year DOTS-Plus pilot experience in India: results, constraints and issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Comprehensive treatment of extensively drug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Adapting a generic tuberculosis control operational guideline and scaling it up in China: a qualitative case study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Side effects associated with the treatment of multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Outcomes of individualised treatment for multidrug-resistant tuberculosis before DOTS-plus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Feasibility of home-based and health centre-based DOT: perspectives of TB care providers and clients in an HIV-endemic area of Thailand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Eleven years of community-based directly observed therapy for tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 September 2017

Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

31 May 2018

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

31 May 2018

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Ethical issues in tuberculosis diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0150511

21 January 2018

Management of multidrug-resistant tuberculosis in Italy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 November 2018

Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 November 2018

Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 November 2018

A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4773051

28 November 2018

Patient care pathways under the model of integrating tuberculosis service with general hospitals in China

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promoting adherence to treatment for tuberculosis: the importance of direct observation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DOT in rural China: experience from a case study in Shandong Province, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuberculosis treatment with mobile-phone medication reminders in northern Thailand

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of hospitalized MDR-TB patients: Israel 2000-2005

1 reference

https://pubmed.ncbi.nlm.nih.gov/26930287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0150511

0 references

2016PLoSO..1150511Y

0 references

1 reference

1 reference

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27013703&oldid=1745251422"